Drug-induced Parkinsonism
📧 Sign up to get email alerts when something new happens for Drug-induced Parkinsonism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: AI-Enhanced Optimization of Acute Levodopa Challenge Test
A Beijing Tiantan Hospital-sponsored clinical trial is evaluating AI-enhanced optimization of the acute levodopa challenge test; the study i…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Effect of Exercise in Parkinsonism [NA]
A completed clinical trial evaluating the effects of exercise in Parkinsonism has posted results, including conditions Parkinson's disease a…
-
FDA approval · 2023-07-03FDA Approved: BENZTROPINE MESYLATE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for benztropine mesylate, submitted by Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes
This entry notes the completion of a clinical trial evaluating transcranial duplex scanning and SPECT imaging in Parkinsonian syndromes cond…
-
FDA approval · 2009-07-28FDA Approved: BENZTROPINE MESYLATE — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original application for benztropine mesylate (generic) by Fresenius Kabi USA, LLC, expanding access to treatment for Parki…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-08-27FDA Approved: BENZTROPINE MESYLATE — Original Application (Endo USA, Inc.)
FDA approves Endo USA's benztropine mesylate as a generic drug under Original Application (ANDA 040715) to treat Parkinson's disease and dru…